Gilead Sciences to Present at the 11th Annual BIO CEO Investor Conference on Tuesday, February 10
February 06 2009 - 4:15PM
Business Wire
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that its
corporate presentation will be webcast from the 11th Annual BIO CEO
Investor Conference in New York.
John F. Milligan, PhD, Gilead�s President and Chief Operating
Officer, will provide an overview of the company on Tuesday,
February 10 at noon Eastern Time.
To access the live webcast via the internet log on to
www.gilead.com. Please connect to the company�s website at least 15
minutes prior to the start of the presentation to ensure adequate
time for any software download that may be necessary to listen to
the webcast.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company�s mission is to advance the care of
patients suffering from life-threatening diseases worldwide.
Headquartered in Foster City, California, Gilead has operations in
North America, Europe and Australia.
For more information on Gilead
Sciences, please visit www.gilead.com orcall the Gilead Public
Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Sep 2024 to Oct 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Oct 2023 to Oct 2024